Oksana A Lenina Selected Research

methoctramine

1/2022

Balanced modulation of neuromuscular synaptic transmission via M1 and M2 muscarinic receptors during inhibition of cholinesterases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Oksana A Lenina Research Topics

Disease

2	Muscle Weakness 01/2022 - 10/2018
2	Poisoning 01/2022 - 10/2020
1	Edema (Dropsy) 08/2021
1	Inflammation (Inflammations) 08/2021
1	Organophosphate Poisoning 10/2020
1	Alzheimer Disease (Alzheimer's Disease) 09/2020
1	Myasthenia Gravis 10/2018

Drug/Important Bio-Agent (IBA)

3	AcetylcholinesteraseIBA 01/2022 - 10/2018
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2022
1	methoctramineIBA 01/2022
1	Atropine FDA LinkGeneric 01/2022
1	Paraoxon (E600)IBA 01/2022
1	PirenzepineIBA 01/2022
1	Liposomes (Liposome)IBA 08/2021
1	CarrageenanIBA 08/2021
1	UracilIBA 09/2020
1	Biological ProductsIBA 09/2020
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 09/2020
1	Cholinesterases (Cholinesterase)IBA 10/2018
1	Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric 10/2018
1	2-(N-cyclohexylamino)ethanesulfonic acid (CHES)IBA 10/2018
1	Cholinergic Agents (Cholinergics)IBA 10/2018

Therapy/Procedure

1	Therapeutics 10/2020